Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) Insider Sells $575,000.00 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Edwin Reisz sold 50,000 shares of the company’s stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $575,000.00. Following the transaction, the insider owned 1,397,897 shares in the company, valued at $16,075,815.50. The trade was a 3.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Aveanna Healthcare Price Performance

Aveanna Healthcare stock traded up $0.54 during mid-day trading on Monday, reaching $13.70. The company had a trading volume of 5,364,375 shares, compared to its average volume of 1,804,109. The stock’s 50-day simple moving average is $9.58 and its 200-day simple moving average is $7.92. Aveanna Healthcare Holdings Inc. has a 1 year low of $5.93 and a 1 year high of $13.98. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. The company has a market capitalization of $2.99 billion, a P/E ratio of 11.14, a P/E/G ratio of 0.92 and a beta of 1.90.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. The business had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. On average, equities analysts predict that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current year.

Institutional Trading of Aveanna Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in AVAH. BlackRock Inc. acquired a new stake in Aveanna Healthcare during the second quarter worth approximately $63,504,000. Vanguard Group Inc. raised its holdings in Aveanna Healthcare by 38.0% in the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after acquiring an additional 1,535,351 shares during the last quarter. Millennium Management LLC raised its holdings in Aveanna Healthcare by 1,007.1% in the 4th quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock valued at $9,107,000 after acquiring an additional 1,014,030 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Aveanna Healthcare during the 2nd quarter worth $7,881,000. Finally, Nuveen LLC boosted its holdings in shares of Aveanna Healthcare by 135.9% during the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after purchasing an additional 905,316 shares during the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

AVAH has been the topic of several research reports. Wall Street Zen lowered Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Truist Financial increased their price objective on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a research note on Monday. Raymond James Financial lifted their target price on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research report on Friday, August 14th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. Finally, BMO Capital Markets increased their price target on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Aveanna Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $12.89.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.